id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-N-4731-0053,FDA,FDA-2025-N-4731,Increasing Access to Nonprescription Drugs Transcript from the 4/23/2026 Public Meeting,Other,Transcript(s),2026-05-04T04:00:00Z,2026,5,2026-05-04T04:00:00Z,,2026-05-04T17:56:38Z,,0,0,09000064b92bda9a
FDA-2025-N-4731-0052,FDA,FDA-2025-N-4731,Increasing Access to Nonprescription Drugs; Public Meeting; Request for Comments,Notice,Request for Comments,2026-04-15T04:00:00Z,2026,4,2026-04-23T04:00:00Z,2026-05-09T03:59:59Z,2026-05-09T09:00:20Z,2026-07335,0,0,09000064b9282192
FDA-2025-N-4731-0001,FDA,FDA-2025-N-4731,Increasing Access to Nonprescription Drugs; Request for Information,Notice,Requests for Information (RFI),2025-12-02T05:00:00Z,2025,12,2025-12-02T05:00:00Z,2026-02-03T04:59:59Z,2026-02-07T13:12:35Z,2025-21728,0,0,09000064b90a9a1a